COF vs CTMX · P/E 62, rev $53.43B vs rev $138.1M
Capital One Financial Corporation (COF) versus CytomX Therapeutics Inc (CTMX) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
COF currently screens at market cap $125.00B and trailing P/E 61.8. CTMX currently screens at market cap $653.1M.
Not investment advice. Open the COF and CTMX stock pages for the full models.
Not investment advice.